2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide

C36H45N11O4 — CID 177160111

IUPAC2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide
SMILESCCc1c(N2CCN(C(=O)c3ncnc(C)c3O)[C@H]3CCC32)c(=O)c2nn(-c3ccn(C4CC4)n3)nc2n1CC(=O)NC12CCC1C(C(C)C)C2
InChIInChI=1S/C36H45N11O4/c1-5-24-31(43-14-15-44(26-9-8-25(26)43)35(51)30-32(49)20(4)37-18-38-30)33(50)29-34(42-47(41-29)27-11-13-46(40-27)21-6-7-21)45(24)17-28(48)39-36-12-10-23(36)22(16-36)19(2)3/h11,13,18-19,21-23,25-26,49H,5-10,12,14-17H2,1-4H3,(H,39,48)/t22?,23?,25?,26-,36?/m0/s1
InChIKeyRSRUYYMNLGMFAJ-MLUCUMPXSA-N
MW695.83 g/mol
LogP2.91
Rot. Bonds9

About 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide

2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide (PubChem CID 177160111) has the molecular formula C36H45N11O4 and a molecular weight of 695.83 g/mol. Its IUPAC name is 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide.

Molecular Properties

Compound Name2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide
PubChem CID177160111
Molecular FormulaC36H45N11O4
Molecular Weight695.83 g/mol
Exact Mass695.37
IUPAC Name2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide
SMILESCCc1c(N2CCN(C(=O)c3ncnc(C)c3O)[C@H]3CCC32)c(=O)c2nn(-c3ccn(C4CC4)n3)nc2n1CC(=O)NC12CCC1C(C(C)C)C2
InChIInChI=1S/C36H45N11O4/c1-5-24-31(43-14-15-44(26-9-8-25(26)43)35(51)30-32(49)20(4)37-18-38-30)33(50)29-34(42-47(41-29)27-11-13-46(40-27)21-6-7-21)45(24)17-28(48)39-36-12-10-23(36)22(16-36)19(2)3/h11,13,18-19,21-23,25-26,49H,5-10,12,14-17H2,1-4H3,(H,39,48)/t22?,23?,25?,26-,36?/m0/s1
InChIKeyRSRUYYMNLGMFAJ-MLUCUMPXSA-N
XLogP2.91
TPSA169.19 Ų
H-Bond Donors2
H-Bond Acceptors13
Rotatable Bonds9
Heavy Atoms51
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500695.83
LogP ≤ 52.91
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1013

Analyze 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide?
The IUPAC name of 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide (CID 177160111) is 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide.
What is the SMILES notation for 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide?
The canonical SMILES for 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide is CCc1c(N2CCN(C(=O)c3ncnc(C)c3O)[C@H]3CCC32)c(=O)c2nn(-c3ccn(C4CC4)n3)nc2n1CC(=O)NC12CCC1C(C(C)C)C2.
What is the InChIKey of 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide?
The InChIKey is RSRUYYMNLGMFAJ-MLUCUMPXSA-N. The full InChI is InChI=1S/C36H45N11O4/c1-5-24-31(43-14-15-44(26-9-8-25(26)43)35(51)30-32(49)20(4)37-18-38-30)33(50)29-34(42-47(41-29)27-11-13-46(40-27)21-6-7-21)45(24)17-28(48)39-36-12-10-23(36)22(16-36)19(2)3/h11,13,18-19,21-23,25-26,49H,5-10,12,14-17H2,1-4H3,(H,39,48)/t22?,23?,25?,26-,36?/m0/s1.
What are the key properties of 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide?
2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide has a molecular weight of 695.83 g/mol, XLogP of 2.91, 9 rotatable bonds, 2 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(1-cyclopropylpyrazol-3-yl)-5-ethyl-6-[(6S)-5-(5-hydroxy-6-methylpyrimidine-4-carbonyl)-2,5-diazabicyclo[4.2.0]octan-2-yl]-7-oxotriazolo[4,5-b]pyridin-4-yl]-N-(3-propan-2-yl-1-bicyclo[2.2.0]hexanyl)acetamide is sourced from PubChem (CID 177160111), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).